Quotient Bioresearch Announce Collaboration with Clinical Reference Laboratory
News Aug 25, 2009
Quotient Bioresearch Limited and Clinical Reference Laboratory have concluded an agreement that will result in the provision of a global clinical laboratory testing capability to support the two Group’s clients world wide.
Under the collaboration, CRL Global Services will set up its European clinical reference laboratory operation within Quotient’s facility in Cambridgeshire, UK, establishing it as the European hub for its Central Laboratory Services unit. This will complement Quotient’s existing clinical laboratory services, particularly in the area of bioanalysis and biomarkers.
Paul Cowan, CEO of Quotient Bioresearch commented: “This collaboration brings exciting new opportunities for our bioanalytical sciences and microbiology businesses. Working in tandem with CRL offers access to a well established, standardized global laboratory infrastructure and the ability to serve the requirements of our clients for global clinical trials.”
Tim Sotos, CEO of Clinical Reference Laboratory added “Quotient Bioresearch is an excellent partner for Clinical Reference Laboratory. Quotient’s strong track record in high quality bioanalytical sciences and early phase drug development is highly complementary to our business and offers significant added value in the provision of central laboratory services.”
Study Extends Potential of Personalized Cell-based ImmunotherapiesNews
New methods developed for the study could be applied to devise personalized, cell-based immunotherapies for epithelial ovarian cancer or other types of tumorsREAD MORE
Hope for Hot Flushes: New Class of Menopause Drugs Reduces SeverityNews
A new class of experimental drugs reduces hot flushes in menopausal women by almost three-quarters in just three days. The new analysis, published in the journal Menopause, also revealed sleep and concentration significantly improved in the three-day window.